Literature DB >> 14698017

Reporting of model validation procedures in human studies of genetic interactions.

Christopher S Coffey1, Patricia R Hebert, Harlan M Krumholz, Thomas M Morgan, Scott M Williams, Jason H Moore.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14698017     DOI： 10.1016/j.nut.2003.09.012

Source DB:  PubMed          Journal:  Nutrition        ISSN： 0899-9007            Impact factor:   4.008


× No keyword cloud information.
  13 in total

1.  Machine learning for detecting gene-gene interactions: a review.

Authors:  Brett A McKinney; David M Reif; Marylyn D Ritchie; Jason H Moore
Journal:  Appl Bioinformatics       Date:  2006

2.  DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Authors:  Angeline S Andrew; Margaret R Karagas; Heather H Nelson; Simonetta Guarrera; Silvia Polidoro; Sara Gamberini; Carlotta Sacerdote; Jason H Moore; Karl T Kelsey; Eugene Demidenko; Paolo Vineis; Giuseppe Matullo
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

3.  Exploring the performance of Multifactor Dimensionality Reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models.

Authors:  Todd L Edwards; Kenneth Lewis; Digna R Velez; Scott Dudek; Marylyn D Ritchie
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

4.  Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis.

Authors:  Benjamin J Grady; Marylyn D Ritchie
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-03-01

5.  A general framework for formal tests of interaction after exhaustive search methods with applications to MDR and MDR-PDT.

Authors:  Todd L Edwards; Stephen D Turner; Eric S Torstenson; Scott M Dudek; Eden R Martin; Marylyn D Ritchie
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

6.  A cross-validation procedure for general pedigrees and matched odds ratio fitness metric implemented for the multifactor dimensionality reduction pedigree disequilibrium test.

Authors:  Todd L Edwards; Eric Torstensen; Scott Dudek; Eden R Martin; Marylyn D Ritchie
Journal:  Genet Epidemiol       Date:  2010-02       Impact factor: 2.135

7.  EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.

Authors:  Rebecca A Mason; Elaine V Morlock; Margaret R Karagas; Karl T Kelsey; Carmen J Marsit; Alan R Schned; Angeline S Andrew
Journal:  Carcinogenesis       Date:  2009-04-16       Impact factor: 4.944

8.  Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.

Authors:  Angeline S Andrew; Jiang Gui; Ting Hu; Asaf Wyszynski; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Sam A Tanyos; Eben M Pendleton; Rebecca M Ekstrom; Zhongze Li; Michael S Zens; Mark Borsuk; Jason H Moore; Margaret R Karagas
Journal:  BJU Int       Date:  2014-03-26       Impact factor: 5.588

9.  A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.

Authors:  Folkert W Asselbergs; Jason H Moore; Maarten P van den Berg; Eric B Rimm; Rudolf A de Boer; Robin P Dullaart; Gerjan Navis; Wiek H van Gilst
Journal:  BMC Med Genet       Date:  2006-04-19       Impact factor: 2.103

10.  SNP-SNP interactions in breast cancer susceptibility.

Authors:  Venüs Ummiye Onay; Laurent Briollais; Julia A Knight; Ellen Shi; Yuanyuan Wang; Sean Wells; Hong Li; Isaac Rajendram; Irene L Andrulis; Hilmi Ozcelik
Journal:  BMC Cancer       Date:  2006-05-03       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.